Optic neuritis, a new variant of experimental encephalomyelitis, a durable model for all seasons, now in its seventieth year.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. Experimental encephalomyelitis at age 90, still relevant and elucidating how viruses trigger disease.The Journal of experimental medicine · 2023
   Article
2. B cells are capable of independently eliciting rapid reactivation of encephalitogenic CD4 T cells in a murine model of multiple sclerosis.PloS one · 2018
   Article
3. Models for Studying Myelination, Demyelination and Remyelination.Neuromolecular medicine · 2017
   Review
4. Multifaceted interactions between adaptive immunity and the central nervous system.Science (New York, N.Y.) · 2016
   Review
5. Interactions of the histamine and hypocretin systems in CNS disorders.Nature reviews. Neurology · 2015
   Review
6. Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future.Expert review of clinical immunology · 2015
   Review
7. Damage to the optic chiasm in myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis mice.Magnetic resonance insights · 2014
   Article
8. B-cell delivered gene therapy for tolerance induction: role of autoantigen-specific B cells.Journal of autoimmunity · 2010
   Article
9. T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis.Immunology · 2008
   Article
10. Prophylactic and therapeutic suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor.Clinical immunology (Orlando, Fla.) · 2008
    Article
11. Reconstitution of paired T cell receptor alpha- and beta-chains from microdissected single cells of human inflammatory tissues.Proceedings of the National Academy of Sciences of the United States of America · 2006
    Article
12. Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor.The Journal of experimental medicine · 2005
    Article
13. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.Immunogenetics · 2005
    Article
14. Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.Proceedings of the National Academy of Sciences of the United States of America · 2004
    Review
15. Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2004
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as